HighTower Advisors’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
HighTower Advisors's ADPT Position: Q3 2026 in Review
HighTower Advisors opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 7,462 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #3491 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in ADPT as recently as Q3 2025.
HighTower Advisors first reported a position in ADPT in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.72M in Q4 2019. 267 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- HighTower Advisors held 7,462 shares of Adaptive Biotechnologies worth $216K as of Q3 2026.
- Adaptive Biotechnologies was a new HighTower Advisors position in Q3 2026.
- Adaptive Biotechnologies made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3491 holding.
- HighTower Advisors first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 24 quarters since.
- HighTower Advisors's Adaptive Biotechnologies position peaked at $1.72M in Q4 2019.
- 267 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.